**Core Concept**
Meningococcal meningitis is a bacterial infection of the meninges, the protective membranes surrounding the brain and spinal cord, caused by Neisseria meningitidis. The empirical treatment for bacterial meningitis typically involves broad-spectrum antibiotics that can cover a wide range of potential pathogens, including N. meningitidis. The Centers for Disease Control and Prevention (CDC) and other organizations recommend empirical treatment with a third-generation cephalosporin, such as ceftriaxone.

**Why the Correct Answer is Right**
Ceftriaxone is a third-generation cephalosporin with broad-spectrum activity against Gram-positive and Gram-negative bacteria, including N. meningitidis. It has excellent penetration into the cerebrospinal fluid (CSF) and is effective against meningococcal strains that are resistant to penicillin. Ceftriaxone's broad-spectrum activity also allows it to cover other potential pathogens that may be causing the meningitis, such as Streptococcus pneumoniae and Haemophilus influenzae. This makes ceftriaxone an ideal empirical treatment option for bacterial meningitis.

**Why Each Wrong Option is Incorrect**
**Option A:** While penicillin is an effective treatment for some bacterial infections, it is not the best empirical treatment option for meningococcal meningitis due to the high rate of penicillin-resistant N. meningitidis strains.
**Option B:** Piperacillin-Tazobactam has a broad-spectrum of activity, but it is not the preferred empirical treatment for bacterial meningitis. Cephalosporins, like ceftriaxone, are generally preferred due to their excellent penetration into the CSF and activity against N. meningitidis.
**Option C:** Cotrimoxazole is effective against some bacterial infections, but it is not the best empirical treatment option for meningococcal meningitis. It may not provide adequate coverage against N. meningitidis, and its use can be limited by resistance and side effects.
**Option D:** Penicillin is an effective treatment for some bacterial infections, but it is not the best empirical treatment option for meningococcal meningitis due to the high rate of penicillin-resistant N. meningitidis strains.

**Clinical Pearl / High-Yield Fact**
Remember that empirical treatment for bacterial meningitis should cover a broad spectrum of potential pathogens, including N. meningitidis. Third-generation cephalosporins, such as ceftriaxone, are generally preferred due to their excellent penetration into the CSF and activity against N. meningitidis.

**Correct Answer Line**
✓ Correct Answer: A. Ceftriaxone